Latest Sectors News
Symbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical company has set a Rs 938-988 price band, with proceeds from the fresh issue earmarked for debt repayment. View More
Pharmaceutical and biotechnology company Symbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its initial public offering (IPO), which opens for public subscription on August 24, 2026. Through the public issue, the company seeks to raise Rs 1,757 crore. The company said it has finalised the allocation of 53,25,909 equity shares to anchor investors at an anchor investor allocation price of Rs 988 per share, including a share premium of Rs 986 per share, aggregating to Rs 526.20 crore. Of the total anchor investor portion, 40% was reserved for domestic mutual funds, life insurance companies and pension funds. Of this, 33.33% was reserved for domestic mutual funds, while 6.67% was reserved for life insurance companies and pension funds. Among the notable investors participating in the anchor book were BNP Paribas Financial Markets – ODI, Citigroup Global Markets Mauritius Private Limited, Baroda BNP Paribas Health and Wellness Fund, Tata AIA Life Insurance Company, Singularity Equity Fund I, ICICI Prudential Smallcap Fund, HDFC Pharma and Healthcare Fund, HDFC MNC Fund, Motilal Oswal Small Cap Fund, Mirae Asset Health Care Fund, Mirae Asset Multi Asset Allocation Fund and Edelweiss Large Cap Fund, among others. Symbiotec Pharmalab IPO details The Symbiotec Pharmalab IPO comprises a fresh issue of 0.15 crore shares aggregating to Rs 150 crore and an offer for sale (OFS) of up to 1.63 crore shares aggregating to Rs 1,607 crore by promoters and investors. Live Events The IPO will open for subscription on August 24, 2026 and close on August 27, 2026. The company has fixed the IPO price band at Rs 938-988 per share. The lot size is 15 shares, meaning investors can bid for a minimum of 15 shares and in multiples thereof. At the upper end of the price band, the minimum investment required by a retail investor is Rs 14,820 for 15 shares. The allotment is expected to be finalised on August 28, 2026, while the shares are proposed to be listed on both the NSE and BSE, with a tentative listing date of September 1, 2026. The company will not receive any proceeds from the offer for sale. The proceeds from the OFS will accrue to the respective selling shareholders, after deducting their share of offer-related expenses and applicable taxes. Proceeds from the fresh issue will be used towards prepayment and/or repayment, in full or in part, of certain outstanding borrowings availed by the company, with the balance being used for general corporate purposes. MUFG Intime India Pvt Ltd is the registrar to the issue, while JM Financial , Avendus Capital, Motilal Oswal Investment Advisors and Nomura Financial Advisory and Securities (India) are the book-running lead managers. ALSO READ: Warren Buffett: If past data told you the future, the Forbes 400 would comprise librarians; beware of geeks bearing formulas About Symbiotec Pharmalab Incorporated in 2002, Symbiotec Pharmalab is a pharmaceutical and biotechnology company engaged in the development and manufacturing of active pharmaceutical ingredients (APIs), nutritional ingredients and specialty products. The company serves domestic and international markets across regulated and emerging regions. The company has approvals from the US Food and Drug Administration (US FDA), European Union Good Manufacturing Practices (EU-GMP), Ministry of Food and Drug Safety, Korea, and other global regulatory organisations. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times) .Pbanner{display:flex;justify-content:space-between;align-items:center;background-color:#ec1c40;margin-top:20px;padding:5px 10px;border-radius:4px;color:#fff;line-height:10px;width: 100%;box-sizing: border-box} .Pbannertext{display:flex;align-items:center;font-size:16px;font-weight:600;font-family:'Montserrat';} .Pbannertext img{height:20px;margin:0 6px} .Pbannerbutton a{display:flex;align-items:center;background-color:#fff;color:#ec1c40;text-decoration:none;font-weight:600;padding:4px 8px;border-radius:6px;font-size:15px;font-family:'Montserrat';} .Pbannerbutton img{height:20px;margin-right:6px} .Pbannerbutton a:hover{background-color:#f7f7f7} Add as a Reliable and Trusted News Source Add Now! (You can now subscribe to our ETMarkets WhatsApp channel) (You can now subscribe to our ETMarkets WhatsApp channel)
Skyways Air Services raised Rs 174.5 crore from anchor investors ahead of its Rs 582.80 crore IPO, opening August 24, 2026. The price band is Rs 131-138 per share, with shares expected to list on September 1, 2026. View More
Air freight forwarder Skyways Air Services has raised Rs 174.5 crore from anchor investors ahead of its initial public offering, which opens for public subscription on Monday, August 24, 2026. The company is looking to raise Rs 582.80 crore through the public issue. Skyways Air Services informed the stock exchanges that it has allocated 1,26,48,000 equity shares at Rs 138 apiece to anchor investors. Among the institutional investors that participated in the anchor book are Nomura Singapore, Citi Group Global Markets Mauritius, Holani Venture Capital Fund - Holani Venture Capital Fund-I, IndusInd General Insurance Company, and ASAS Global Fund Incorporated VCC Sub Fund. Among equity-oriented schemes, the company has allocated shares to Bank of India Small Cap Fund and Taurus Flexi Cap Fund. Of the total allocation of 1,26,48,000 equity shares to anchor investors, 50,50,000 shares were allocated to two domestic mutual funds through six schemes, the company said. ALSO READ: PSU banks offer highest alpha potential; IT faces uncertainty: Omniscience Capital Live Events Skyways Air Services IPO details The Skyways Air Services IPO comprises a fresh issue of 2.89 crore shares aggregating to Rs 398.80 crore and an offer for sale (OFS) of up to 1.33 crore shares worth Rs 184 crore by promoters and other selling shareholders. The IPO will open for subscription on August 24, 2026 and close on August 27, 2026. The price band has been fixed at Rs 131-138 per share. The lot size for the IPO is 100 shares, meaning investors can bid for a minimum of 100 shares and in multiples thereof. At the upper end of the price band, the minimum investment required for retail investors is Rs 13,800 for one lot of 100 shares. The allotment is expected to be finalised on August 28, while the shares are tentatively scheduled to list on the exchanges on September 1, 2026. The company said it will not receive any proceeds from the OFS. The proceeds from the offer for sale will accrue to the promoter and other selling shareholders. Of the proceeds from the fresh issue, Rs 216.7 crore will be used towards repayment or prepayment of certain outstanding borrowings availed by the company and its subsidiary, Forin Container Line Private Limited. Another Rs 130 crore will be used to fund incremental working capital requirements to support the company’s growing logistics operations. The remaining proceeds will be utilised towards general corporate purposes and issue-related expenses, the company said. Bigshare Services is the registrar to the issue, while Holani Consultants, Shannon Advisors and Dolat Finserv are the book-running lead managers. About Skyways Air Services Skyways Air Services, incorporated in 1984, is an integrated logistics and supply chain solutions provider offering air freight, ocean freight, contract logistics, warehousing, customs clearance and value-added logistics services. The company operates across the logistics value chain and caters to industries requiring domestic and international cargo movement. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times) .Pbanner{display:flex;justify-content:space-between;align-items:center;background-color:#ec1c40;margin-top:20px;padding:5px 10px;border-radius:4px;color:#fff;line-height:10px;width: 100%;box-sizing: border-box} .Pbannertext{display:flex;align-items:center;font-size:16px;font-weight:600;font-family:'Montserrat';} .Pbannertext img{height:20px;margin:0 6px} .Pbannerbutton a{display:flex;align-items:center;background-color:#fff;color:#ec1c40;text-decoration:none;font-weight:600;padding:4px 8px;border-radius:6px;font-size:15px;font-family:'Montserrat';} .Pbannerbutton img{height:20px;margin-right:6px} .Pbannerbutton a:hover{background-color:#f7f7f7} Add as a Reliable and Trusted News Source Add Now! (You can now subscribe to our ETMarkets WhatsApp channel) (You can now subscribe to our ETMarkets WhatsApp channel)
Centre is discussing the issue with states amid industry concerns that denial of input tax credit on construction of own-use assets raises the cost of large investments View More
The acquisition at Kharadi Knowledge Park includes leasehold rights to an 8,581-square-metre land parcel, ownership of a 15-storey building and 200 parking spaces View More
Lumino Industries has announced its IPO price range set between Rs 78 and Rs 82 per share. This Rs 700 crore offering will be available for subscription from August 27 to August 31. The plan includes a fresh issue of Rs 500 crore alongside an offer-for-sale of Rs 200 crore. Funds raised are earmarked for debt repayment and upgrading equipment, furthering their focus on power cable and electrical wire manufacturing. View More
Lumino Industries Ltd on Friday fixed the price band for its maiden initial public offering at Rs 78-82 per equity share of face value Rs 5 each. The Rs 700-crore issue will open for subscription on August 27, and close on August 31, the Kolkata-based company said in a statement. The offer comprises a fresh issue of equity shares aggregating up to Rs 500 crore and an offer-for-sale of up to Rs 200 crore by promoters. Of the fresh issue proceeds , Rs 337 crore will be used for prepayment or repayment, in full or part, of certain outstanding borrowings, Rs 15.01 crore for capital expenditure towards purchase of equipment, machinery and civil works at an existing manufacturing facility, and the remainder for general corporate purposes, it said. The company is a product-driven, integrated engineering, procurement and construction (EPC) player with focus on manufacturing and supplying conductors, power cables and electrical wires. Live Events The equity shares are proposed to be listed on the BSE and NSE. .Pbanner{display:flex;justify-content:space-between;align-items:center;background-color:#ec1c40;margin-top:20px;padding:5px 10px;border-radius:4px;color:#fff;line-height:10px;width: 100%;box-sizing: border-box} .Pbannertext{display:flex;align-items:center;font-size:16px;font-weight:600;font-family:'Montserrat';} .Pbannertext img{height:20px;margin:0 6px} .Pbannerbutton a{display:flex;align-items:center;background-color:#fff;color:#ec1c40;text-decoration:none;font-weight:600;padding:4px 8px;border-radius:6px;font-size:15px;font-family:'Montserrat';} .Pbannerbutton img{height:20px;margin-right:6px} .Pbannerbutton a:hover{background-color:#f7f7f7} Add as a Reliable and Trusted News Source Add Now! (You can now subscribe to our ETMarkets WhatsApp channel) (You can now subscribe to our ETMarkets WhatsApp channel)
Mumbai recorded 1,499 luxury residential transactions priced
above ?5 Crore between April and June 2026. View More
?414 crore gets SBI a 1.84-lakh-sq-ft building outright, plus leasehold rights over the 8,581-sq-metre land beneath it. View More
Nobel Hygiene has filed its DRHP with SEBI for an IPO comprising a fresh issue of up to Rs 150 crore and an offer for sale of up to 15.51 million shares. The company plans to use the fresh issue proceeds for debt repayment, subsidiary investment and manufacturing expansion, as it seeks to capitalise on India’s fast-growing adult absorbent hygiene market. View More
Nobel Hygiene Limited, a pioneer in India’s adult absorbent hygiene market, has taken a significant step towards going public, filing its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI). Backed by Quadria Capital, the company is looking to tap the public markets as demand for adult, baby and feminine hygiene products accelerates across India. The proposed IPO comprises a fresh issue of equity shares worth up to Rs 150 crore, along with an offer for sale (OFS) of up to 15,511,082 equity shares by existing shareholders. The selling shareholders include promoters Kamal Kumar Johari and Kamini Kamal Johari, as well as investors such as Orbit Investment Holdings Pte. Ltd., Sixth Sense India Opportunities III, Bennett Trading LLP, Manish Dharanendra Ladage, Seema Manish Ladage and Lashit Lallubhai Sanghvi. IPO to fuel capacity expansion and debt reduction Nobel Hygiene plans to deploy the proceeds from the fresh issue towards prepayment or repayment of outstanding borrowings, investment in its subsidiary Nobel Hygiene Baroda Private Limited (NHBPL), and expansion of its manufacturing infrastructure. A key part of the expansion is the proposed augmentation of production capacity at Halol, including the development of a brownfield manufacturing-cum-warehousing facility on the company’s existing land. The company also plans to purchase and install an additional adult diaper machine line. The remaining proceeds will be used for general corporate purposes. Live Events About Nobel Hygiene Nobel Hygiene’s manufacturing and distribution footprint gives it a broad reach across the Indian market. The company operates 14 manufacturing lines across approximately 19 acres at its Nashik and Halol facilities, with an aggregate annual installed capacity of around 1,890.57 million units across adult diapers, baby diapers and underpads. On the distribution side, its network reaches approximately 0.27 million retail outlets across 31 States and Union Territories, supported by more than 296 stockists and 418 distributors. The company has also built an international presence, exporting its products to 19 countries, including Sri Lanka, the United Arab Emirates, Australia and Mauritius. Stronger financial performance Nobel Hygiene’s recent financial performance points to improving scale and profitability. Revenue from operations rose 14.56% to Rs 846.75 crore in FY2026, compared with Rs 739.14 crore in FY2025. Over the same period, EBITDA increased from Rs 65.57 crore to Rs 84.76 crore, while the EBITDA margin expanded from 8.87% to 10.01%. The company also moved decisively into the black. Restated profit for the year increased from just Rs 22.8 lakh in FY2025 to Rs 18.91 crore in FY2026. Product margins improved as well, rising from 42.13% to 44.43% during the year, signalling better operating economics alongside revenue growth. Betting on India’s next hygiene growth wave Nobel Hygiene’s IPO comes at a time when India’s adult absorbent hygiene market is undergoing a major shift. According to the DRHP, the Indian adult absorbent hygiene market was valued at approximately Rs 20.5 billion-Rs 21.5 billion in FY2026, having expanded at a CAGR of around 26% since FY2020. The growth runway could remain substantial. The market is projected to reach Rs 54 billion-Rs 61 billion by FY2031, implying a CAGR of approximately 21%-23%. The opportunity is being driven less by replacement demand and more by the addition of new consumers. The DRHP estimates that 1.5 million-1.8 million new users could enter the category by FY2031. Low penetration, rising awareness, increased recommendations from pharmacists and healthcare professionals, and declining social stigma around adult hygiene products are expected to accelerate adoption. Building a hygiene portfolio across generations With more than two decades of operating history, Nobel Hygiene has built a diversified portfolio spanning adult, baby and feminine absorbent hygiene products. Its brands include Friends, B-Fit, Teddyy, Snuggy and RIO, with the portfolio comprising more than 1,158 SKUs as of March 31, 2026. These products cover adult and baby diapers, underpads, insert pads, maternity pads, bed bath towels, wet wipes and sanitary pads. The company has established a particularly strong foothold in adult hygiene. Friends is India's largest adult absorbent hygiene brand by value, according to the DRHP, while Nobel Hygiene has expanded its portfolio across different price points and consumer needs. The company’s revenue mix also highlights the strength of its two core categories. In FY2026, adult absorbent hygiene accounted for 49.25% of revenue from operations, while baby absorbent hygiene contributed another 45.32%. Friends and Teddyy contributed 37.85% and 39.63%, respectively, while B-Fit accounted for 10.83%. Expanding beyond adult and baby hygiene Nobel Hygiene is also looking to broaden its presence in feminine hygiene, including plans to introduce disposable period panties. At the same time, the company intends to deepen its adult and baby hygiene businesses through wider market penetration, product innovation and increased manufacturing capacity. For a company that helped create India’s organised adult absorbent hygiene market, the IPO represents more than a capital-raising exercise. It comes at a potentially pivotal moment for the category, as changing demographics, rising awareness and greater acceptance of hygiene products create a larger addressable consumer base. ICICI Securities Limited, Motilal Oswal Investment Advisors Limited and SBI Capital Markets Limited are the Book Running Lead Managers to the issue. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times) .Pbanner{display:flex;justify-content:space-between;align-items:center;background-color:#ec1c40;margin-top:20px;padding:5px 10px;border-radius:4px;color:#fff;line-height:10px;width: 100%;box-sizing: border-box} .Pbannertext{display:flex;align-items:center;font-size:16px;font-weight:600;font-family:'Montserrat';} .Pbannertext img{height:20px;margin:0 6px} .Pbannerbutton a{display:flex;align-items:center;background-color:#fff;color:#ec1c40;text-decoration:none;font-weight:600;padding:4px 8px;border-radius:6px;font-size:15px;font-family:'Montserrat';} .Pbannerbutton img{height:20px;margin-right:6px} .Pbannerbutton a:hover{background-color:#f7f7f7} Add as a Reliable and Trusted News Source Add Now! (You can now subscribe to our ETMarkets WhatsApp channel) (You can now subscribe to our ETMarkets WhatsApp channel)
India plans a $1.2 billion incentive scheme for advanced equipment manufacturing. This initiative aims to reduce reliance on China for critical machinery. The government expects fresh investment and domestic production growth over seven years. The scheme will cover tunnel boring machines and fire-fighting equipment. This move supports India's growing infrastructure development needs. View More
India's first large-scale biopolymer plant in Lakhimpur Kheri is nearing its October operational launch. This pioneering project will convert locally grown sugarcane into PLA-based bioplastic. The facility features a Zero Liquid Discharge system to prevent harmful liquid waste. Chief Minister Yogi Adityanath laid the foundation stone for this significant industrial development. View More
Lakhimpur Kheri (UP): India's first large-scale biopolymer plant, being built at an investment of Rs 3,080 crore in Lakhimpur Kheri district, is likely to become operational in October, officials said. Kheri District Magistrate Anjani Kumar Singh on Thursday inspected the under-construction plant and reviewed its progress ahead of its proposed launch in October. Singh said the entire manufacturing process, from locally grown sugarcane to Polylactic Acid (PLA)-based bioplastic, would take place on a single campus. "The pioneering project will add a new chapter to Kheri's agriculture-based industrial development and provide a new direction to sustainable and eco-friendly industrial growth in the area," he said. During the inspection plant officials gave a presentation on the facility's layout and various stages of production. Live Events The District Magistrate examined the process of converting sugarcane into sugar and subsequently into PLA bioplastic and sought details about technical aspects and production workflows. A major feature of the facility is its Zero Liquid Discharge (ZLD) system, which is designed to ensure that no harmful liquid waste is discharged into rivers or drains, officials said. Uttar Pradesh Chief Minister Yogi Adityanath had laid the foundation stone for the plant at the Kumbhi sugar unit of Balrampur Chini Mills in Gola Gokarannath on February 22, 2025. During his visit, Adityanath had said the project would promote environment-friendly products and create employment opportunities for local youth. .Pbanner{display:flex;justify-content:space-between;align-items:center;background-color:#ec1c40;margin-top:20px;padding:5px 10px;border-radius:4px;color:#fff;line-height:10px;width: 100%;box-sizing: border-box} .Pbannertext{display:flex;align-items:center;font-size:16px;font-weight:600;font-family:'Montserrat';} .Pbannertext img{height:20px;margin:0 6px} .Pbannerbutton a{display:flex;align-items:center;background-color:#fff;color:#ec1c40;text-decoration:none;font-weight:600;padding:4px 8px;border-radius:6px;font-size:15px;font-family:'Montserrat';} .Pbannerbutton img{height:20px;margin-right:6px} .Pbannerbutton a:hover{background-color:#f7f7f7} Add as a Reliable and Trusted News Source Add Now! (You can now subscribe to our Economic Times WhatsApp channel) (You can now subscribe to our Economic Times WhatsApp channel)